Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with MS.
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with MS.
Department of Neurology,
University of Texas
Southwestern Medical Center at
Dallas, USA.
BACKGROUND:
